Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cantel Medical (CMD) shares

Learn how to easily invest in Cantel Medical shares.

Cantel Medical is a medical instruments & supplies business based in the US. Cantel Medical stocks (CMD.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $80.37 – a decrease of 0.06% over the previous week. Cantel Medical employs 3,669 staff and has a trailing 12-month revenue of around $1.1 billion.

How to buy shares in Cantel Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cantel Medical stock price (NYSE:CMD)

Use our graph to track the performance of CMD stocks over time.

Cantel Medical shares at a glance

Information last updated 2021-07-25.
Latest market close$81.33
52-week range$72.64 - $89.76
50-day moving average $84.60
200-day moving average $78.78
Wall St. target price$62.00
PE ratio 67.8228
Dividend yield $0.105 (0.13%)
Earnings per share (TTM) $1.19

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Cantel Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cantel Medical price performance over time

Historical closes compared with the close of $81.33 from 2021-05-28

1 week (2022-01-17) N/A
1 month (2021-12-24) N/A
3 months (2021-10-24) N/A
6 months (2021-07-24) N/A
1 year (2021-01-28) 2.29%
2 years (2020-01-28) 18.63%
3 years (2019-01-28) 3.91%
5 years (2017-01-27) 3.47%

Is Cantel Medical under- or over-valued?

Valuing Cantel Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cantel Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cantel Medical's P/E ratio

Cantel Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 68x. In other words, Cantel Medical shares trade at around 68x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Cantel Medical's PEG ratio

Cantel Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4004. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cantel Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Cantel Medical's EBITDA

Cantel Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $247.5 million.

The EBITDA is a measure of a Cantel Medical's overall financial performance and is widely used to measure a its profitability.

Cantel Medical financials

Revenue TTM $1.1 billion
Operating margin TTM 15.65%
Gross profit TTM $462.6 million
Return on assets TTM 5.65%
Return on equity TTM 606.14%
Profit margin 4.57%
Book value $19.66
Market capitalisation $3.4 billion

TTM: trailing 12 months

Cantel Medical share dividends

We're not expecting Cantel Medical to pay a dividend over the next 12 months.

Have Cantel Medical's shares ever split?

Cantel Medical's shares were split on a 3:2 basis on 14 July 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cantel Medical shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cantel Medical shares which in turn could have impacted Cantel Medical's share price.

Cantel Medical share price volatility

Over the last 12 months, Cantel Medical's shares have ranged in value from as little as $72.64 up to $89.76. A popular way to gauge a stock's volatility is its "beta".

CMD.US volatility(beta: 1.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cantel Medical's is 1.5476. This would suggest that Cantel Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cantel Medical overview

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants.

Cantel Medical in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site